Calvo B, Schembri-Wismayer P, Duran-Alonso M
Cells. 2025; 14(5).
PMID: 40072076
PMC: 11898746.
DOI: 10.3390/cells14050347.
Spence J, Mostafavi H, Ota M, Milind N, Gjorgjieva T, Smith C
bioRxiv. 2025; .
PMID: 39935885
PMC: 11812597.
DOI: 10.1101/2024.12.12.628073.
Liu S, Li H, Xi S, Zhang Y, Sun T
Int J Nanomedicine. 2025; 20:1443-1490.
PMID: 39925682
PMC: 11806685.
DOI: 10.2147/IJN.S457393.
De Beuckeleer S, Van De Looverbosch T, Van Den Daele J, Ponsaerts P, De Vos W
Elife. 2025; 13.
PMID: 39819559
PMC: 11741521.
DOI: 10.7554/eLife.95273.
Zhao X, Sun Q, Shou Y, Chen W, Wang M, Qu W
Elife. 2024; 13.
PMID: 39671308
PMC: 11643624.
DOI: 10.7554/eLife.98081.
Breaking the mold: 3D cell cultures reshaping the future of cancer research.
Cordeiro S, Oliveira B, Valente R, Ferreira D, Luz A, Baptista P
Front Cell Dev Biol. 2024; 12:1507388.
PMID: 39659521
PMC: 11628512.
DOI: 10.3389/fcell.2024.1507388.
Epileptiform activity in brain organoids derived from patient with Glucose Transporter 1 Deficiency Syndrome.
Muller Y, Lengacher L, Friscourt F, Quairiaux C, Stoppini L, Magistretti P
Front Neurosci. 2024; 18:1498801.
PMID: 39605786
PMC: 11599213.
DOI: 10.3389/fnins.2024.1498801.
Human brain organoids for understanding substance use disorders.
Li K, Gu L, Cai H, Lu H, Mackie K, Guo F
Drug Metab Pharmacokinet. 2024; 60:101036.
PMID: 39567282
PMC: 11825288.
DOI: 10.1016/j.dmpk.2024.101036.
Artificial Intelligence: Fundamentals and Breakthrough Applications in Epilepsy.
Kerr W, Acosta S, Kwan P, Worrell G, Mikati M
Epilepsy Curr. 2024; :15357597241238526.
PMID: 39554271
PMC: 11562289.
DOI: 10.1177/15357597241238526.
A tumorigenicity evaluation platform for cell therapies based on brain organoids.
Xue J, Chu Y, Huang Y, Chen M, Sun M, Fan Z
Transl Neurodegener. 2024; 13(1):53.
PMID: 39472972
PMC: 11520457.
DOI: 10.1186/s40035-024-00446-5.
The use of induced pluripotent stem cells as a platform for the study of depression.
Villafranco J, Martinez-Ramirez G, Magana-Maldonado R, Gonzalez-Ruvalcaba A, Lopez-Ornelas A, Velasco I
Front Psychiatry. 2024; 15:1470642.
PMID: 39444629
PMC: 11496182.
DOI: 10.3389/fpsyt.2024.1470642.
A polarized FGF8 source specifies frontotemporal signatures in spatially oriented cell populations of cortical assembloids.
Bosone C, Castaldi D, Burkard T, Guzman S, Wyatt T, Cheroni C
Nat Methods. 2024; 21(11):2147-2159.
PMID: 39294368
PMC: 11541204.
DOI: 10.1038/s41592-024-02412-5.
Molecular pathology, developmental changes and synaptic dysfunction in (pre-) symptomatic human C9ORF72-ALS/FTD cerebral organoids.
van der Geest A, Jakobs C, Ljubikj T, Huffels C, Canizares Luna M, Vieira de Sa R
Acta Neuropathol Commun. 2024; 12(1):152.
PMID: 39289761
PMC: 11409520.
DOI: 10.1186/s40478-024-01857-1.
Organoids and chimeras: the hopeful fusion transforming traumatic brain injury research.
Bellotti C, Samudyata S, Thams S, Sellgren C, Rostami E
Acta Neuropathol Commun. 2024; 12(1):141.
PMID: 39215375
PMC: 11363608.
DOI: 10.1186/s40478-024-01845-5.
Advances and challenges in modeling inherited peripheral neuropathies using iPSCs.
Van Lent J, Prior R, Perez Siles G, Cutrupi A, Kennerson M, Vangansewinkel T
Exp Mol Med. 2024; 56(6):1348-1364.
PMID: 38825644
PMC: 11263568.
DOI: 10.1038/s12276-024-01250-x.
Organoids as preclinical models of human disease: progress and applications.
Chen B, Du C, Wang M, Guo J, Liu X
Med Rev (2021). 2024; 4(2):129-153.
PMID: 38680680
PMC: 11046574.
DOI: 10.1515/mr-2023-0047.
Brain Organoids: A Game-Changer for Drug Testing.
Giorgi C, Lombardozzi G, Ammannito F, Scenna M, Maceroni E, Quintiliani M
Pharmaceutics. 2024; 16(4).
PMID: 38675104
PMC: 11054008.
DOI: 10.3390/pharmaceutics16040443.
Organoids Modeling Stroke in a Petri Dish.
Giorgi C, Castelli V, dAngelo M, Cimini A
Biomedicines. 2024; 12(4).
PMID: 38672231
PMC: 11048104.
DOI: 10.3390/biomedicines12040877.
Simple modeling of familial Alzheimer's disease using human pluripotent stem cell-derived cerebral organoid technology.
Choe M, Yeo H, Kim J, Lee J, Lee H, Kim H
Stem Cell Res Ther. 2024; 15(1):118.
PMID: 38659053
PMC: 11040922.
DOI: 10.1186/s13287-024-03732-1.
Chronic Opioid Treatment Arrests Neurodevelopment and Alters Synaptic Activity in Human Midbrain Organoids.
Kim H, Xiao Y, Chen X, He S, Im J, Willner M
Adv Sci (Weinh). 2024; 11(21):e2400847.
PMID: 38549185
PMC: 11151039.
DOI: 10.1002/advs.202400847.